IL52448A - Antimycotic and sporicidal pharmaceutical compositions comprising imidazol-1-yl-(4-phenoxy-phenyl)-(pyridin-2-yl)phenyl methane - Google Patents

Antimycotic and sporicidal pharmaceutical compositions comprising imidazol-1-yl-(4-phenoxy-phenyl)-(pyridin-2-yl)phenyl methane

Info

Publication number
IL52448A
IL52448A IL52448A IL5244877A IL52448A IL 52448 A IL52448 A IL 52448A IL 52448 A IL52448 A IL 52448A IL 5244877 A IL5244877 A IL 5244877A IL 52448 A IL52448 A IL 52448A
Authority
IL
Israel
Prior art keywords
phenyl
sporicidal
antimycotic
imidazol
pyridin
Prior art date
Application number
IL52448A
Other languages
English (en)
Other versions
IL52448A0 (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2630252A external-priority patent/DE2630252C3/de
Priority claimed from DE19772709964 external-priority patent/DE2709964A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL52448A0 publication Critical patent/IL52448A0/xx
Publication of IL52448A publication Critical patent/IL52448A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL52448A 1976-07-06 1977-07-04 Antimycotic and sporicidal pharmaceutical compositions comprising imidazol-1-yl-(4-phenoxy-phenyl)-(pyridin-2-yl)phenyl methane IL52448A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2630252A DE2630252C3 (de) 1976-07-06 1976-07-06 Verwendung von Imidazol-1-yl-(4-phenoxyphenyl)-(pyridin-2-yl)phenylmethan bei der lokalen Bekämpfung von Dermatomykosen
DE19772709964 DE2709964A1 (de) 1977-03-08 1977-03-08 Antimikrobielles mittel

Publications (2)

Publication Number Publication Date
IL52448A0 IL52448A0 (en) 1977-10-31
IL52448A true IL52448A (en) 1981-09-13

Family

ID=25770663

Family Applications (1)

Application Number Title Priority Date Filing Date
IL52448A IL52448A (en) 1976-07-06 1977-07-04 Antimycotic and sporicidal pharmaceutical compositions comprising imidazol-1-yl-(4-phenoxy-phenyl)-(pyridin-2-yl)phenyl methane

Country Status (6)

Country Link
US (1) US4141981A (en:Method)
JP (1) JPS536426A (en:Method)
AU (1) AU511410B2 (en:Method)
FR (1) FR2357250A1 (en:Method)
IL (1) IL52448A (en:Method)
NZ (1) NZ184548A (en:Method)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
JP2008539047A (ja) 2005-04-28 2008-11-13 プロテウス バイオメディカル インコーポレイテッド ファーマインフォーマティックスシステム
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
PT2398500T (pt) 2009-02-20 2019-06-14 2 Bbb Medicines B V Sistema de entrega de medicamentos à base de glutationas
CN102458374A (zh) 2009-05-06 2012-05-16 实验室护肤股份有限公司 包含活性剂-磷酸钙颗粒复合物的皮肤递送组合物及其使用方法
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103254136B (zh) * 2013-05-30 2015-03-25 苏州大学 一种制备四[4-(1-咪唑基)苯基]甲烷的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009020C3 (de) * 1970-02-26 1979-09-13 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung von N-(l,l,l-trisubstituierten)-Methylazolen
DE2016839C3 (de) * 1970-04-09 1979-03-22 Bayer Ag, 5090 Leverkusen PhenyM4-phenoxyphenyi)-imidazol-1-yl-methane, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
IL52448A0 (en) 1977-10-31
US4141981A (en) 1979-02-27
AU511410B2 (en) 1980-08-21
AU2678777A (en) 1979-01-11
NZ184548A (en) 1981-10-19
JPS536426A (en) 1978-01-20
FR2357250B1 (en:Method) 1980-06-27
FR2357250A1 (fr) 1978-02-03

Similar Documents

Publication Publication Date Title
JPS5340767A (en) Heterocyclic phenyl ether and hervicide containing same
ZA774694B (en) Stabilized dentifrice
JPS52114026A (en) Pharmaceutical composition having antiiinflammation activity
HU179590B (en) Insecticide composition
GB1555723A (en) N-acyl-substitued benzamides
ZA776910B (en) Insecticide composition
NZ183551A (en) Aminochromanols and pharmaceutical compositions containingthem
NZ184953A (en) 2-cyclopropylamino-4 6-diamino-s-triazines and insecticidal compositions
NZ184848A (en) Azolyl-carboxylic acid derivatives and fungicidal compositions
AU512764B2 (en) Substituted ketones and their use as fungicides
IL52448A (en) Antimycotic and sporicidal pharmaceutical compositions comprising imidazol-1-yl-(4-phenoxy-phenyl)-(pyridin-2-yl)phenyl methane
EG12330A (en) Novel acylated triazolyl-o,n-acetals and their use as fungicides
EG12479A (en) 1-(2-halogeno-2-phenyl-ethyl)-triazoles and their use as fungicides
ZA775234B (en) Biocidal composition
NZ183549A (en) Amidinopencillanoyloxy-alkyl-amoxycillinates and pharmaceutical compositions
GB1539678A (en) Fungicides
NZ184808A (en) Heterocyclic compounds and pharmaceutical compositions
NZ185319A (en) 1-(n-acylcarbamoyl)-2-cyanoaziridines and pharmaceutical compositions
GB1538412A (en) Oxime-ethers and their use as fungicides
IL51380A0 (en) Acylated imidazolyl-o,n-acetals their preparation and their use as fungicides
GB1520710A (en) 1 - acyloxy - 1-phenyl - 2 - azolyl - ethanes and their use as fungicides or nematocides
NZ183756A (en) Bis-penicillanoyloxy-alkanes and pharmaceutical compositions
NZ185188A (en) 0-alkyl-n-dialkylsulphamyl-phosphorami-dothiolate and pesticidal compositions
JPS5384989A (en) Tetrathiapentalene and tetraselenapentalene compounds
JPS5386039A (en) Pharmaceutical composition having antiitumor activity